Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced... Letters to the Editor Conflict of interest 2 Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C et al. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood 2009; The authors declare no conflict of interest. 113: 6182–6192. 3 Carbuccia N, Murati A, Trouplin V, Brecqueville M, Ade ´ laıde J, Acknowledgements Rey J et al. Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia 2009; 23: 2183–2186. This study was supported by a grant from the Else Kro ¨ ner- 4 Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs Jr KD et al. Fresenius-Stiftung (project P28/07//A56/07); LB was supported in Novel mutations in the inhibitory adaptor protein LNK drive JAK- STAT signaling in patients with myeloproliferative neoplasms. Blood part by the Deutsche Forschungsgemeinschaft (BU 1339/3-1). 2010; 116: 988–992. 1 1 1 1 F Stegelmann , L Bullinger , RF Schlenk , P Paschka , 5 Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, 2 1 1 1 M Griesshammer , C Blersch , S Kuhn , S Schauer , Masse ´ A et al. Mutation in TET2 in myeloid cancers. N Engl J Med 1 1 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Leukemia Springer Journals

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

Loading next page...
 
/lp/springer-journals/dnmt3a-mutational-analysis-in-primary-myelofibrosis-chronic-oqj0415rKa

References (13)

Publisher
Springer Journals
Copyright
Copyright © 2011 by Macmillan Publishers Limited
Subject
Medicine & Public Health; Medicine/Public Health, general; Internal Medicine; Intensive / Critical Care Medicine; Cancer Research; Oncology; Hematology
ISSN
0887-6924
eISSN
1476-5551
DOI
10.1038/leu.2011.82
Publisher site
See Article on Publisher Site

Abstract

Letters to the Editor Conflict of interest 2 Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C et al. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood 2009; The authors declare no conflict of interest. 113: 6182–6192. 3 Carbuccia N, Murati A, Trouplin V, Brecqueville M, Ade ´ laıde J, Acknowledgements Rey J et al. Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia 2009; 23: 2183–2186. This study was supported by a grant from the Else Kro ¨ ner- 4 Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs Jr KD et al. Fresenius-Stiftung (project P28/07//A56/07); LB was supported in Novel mutations in the inhibitory adaptor protein LNK drive JAK- STAT signaling in patients with myeloproliferative neoplasms. Blood part by the Deutsche Forschungsgemeinschaft (BU 1339/3-1). 2010; 116: 988–992. 1 1 1 1 F Stegelmann , L Bullinger , RF Schlenk , P Paschka , 5 Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, 2 1 1 1 M Griesshammer , C Blersch , S Kuhn , S Schauer , Masse ´ A et al. Mutation in TET2 in myeloid cancers. N Engl J Med 1 1

Journal

LeukemiaSpringer Journals

Published: Apr 26, 2011

There are no references for this article.